Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 (Gastric Cancer, (2021), 10.1007/s10120-021-01200-w)

Eric Van Cutsem, Mayur Amonkar, Charles S. Fuchs, Maria Alsina, Mustafa Özgüroğlu, Yung Jue Bang, Hyun Cheol Chung, Kei Muro, Eray Goekkurt, Al B. Benson, Weijing Sun, Zev A. Wainberg, Josephine M. Norquist, Xinqun Chen, Chie Schin Shih, Kohei Shitara

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original publication of the article, the following sentences should be added before last under the “Declarations” heading.

Original languageEnglish
JournalGastric Cancer
DOIs
Publication statusAccepted/In press - 2021

Bibliographical note

Publisher Copyright:
© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021.

All Science Journal Classification (ASJC) codes

  • Oncology
  • Gastroenterology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 (Gastric Cancer, (2021), 10.1007/s10120-021-01200-w)'. Together they form a unique fingerprint.

Cite this